The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer

Zhang, Wunai; He, Rui; Chen, Shuo; Zhang, Li; Cao, Gang; Yang, Wenbin; Li, Junhui

doi:10.7150/jca.40953



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2020; 11(11):3246-3255. doi:10.7150/jca.40953 This issue Cite

Research Paper

The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer

Wunai Zhang^1,2*, Rui He^3*, Shuo Chen¹, Li Zhang¹, Gang Cao¹, Wenbin Yang^1✉, Junhui Li^1✉

1. Department of General Surgery, Second Affiliated Hospital, Xi'an Jiaotong University, 157 West 5 th Road, Xi'an, 710004, China.
2. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
3. Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5 th Road, Xi'an, 710004, China.
*These authors have contributed equally to this work.

Citation:

Zhang W, He R, Chen S, Zhang L, Cao G, Yang W, Li J. The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer. J Cancer 2020; 11(11):3246-3255. doi:10.7150/jca.40953. https://www.jcancer.org/v11p3246.htm

Other styles

Abstract

Junctional adhesion molecule B (JAM-B) is a multifunctional transmembrane protein that plays an important role in tumor progression. JAM-B is significantly upregulated in gastric cancer, melanoma cell metastasis and oral squamous cell carcinoma. JAM-2 may also function as a putative tumor suppressor in the progression and metastasis of colorectal cancer. The inconsistency of the results in different cancers has led to uncertainty regarding the role of JAM-B in carcinogenesis. For this purpose, the expression levels of JAM-B in pancreatic cancer (PanCa) tissues were associated with T stage and lymph node involvement with significant differences. A relatively high expression of JAM-B was found in PanCa cell lines by immunohistochemistry and western blot analysis. By cell transfection, JAM-B was silenced in tumor cell lines to determine cell invasion and migration abilities. Scratch wound assays and Transwell assays revealed that shJAM-B significantly decreased Panc-1 cell migration and invasion. Experiments were also conducted using a subcutaneous PanCa nude mouse model. A significant difference in tumor diameter at the injection site was found between the control group and the JAM-B low expression group. The expression levels of c-Src and MMP9 were also significantly reduced compared to that in the control group by immunohistochemistry. In conclusion, our results suggest that JAM-B secreted by cancer cells can promote progression and invasion in PanCa by upregulating the c-Src signal and related downstream proteins.

Keywords: JAM-B, c-src, pancreatic cancer, progression, invasion

Citation styles

APA

Zhang, W., He, R., Chen, S., Zhang, L., Cao, G., Yang, W., Li, J. (2020). The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer. Journal of Cancer, 11(11), 3246-3255. https://doi.org/10.7150/jca.40953.

ACS

Zhang, W.; He, R.; Chen, S.; Zhang, L.; Cao, G.; Yang, W.; Li, J. The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer. J. Cancer 2020, 11 (11), 3246-3255. DOI: 10.7150/jca.40953.

NLM

CSE

Zhang W, He R, Chen S, Zhang L, Cao G, Yang W, Li J. 2020. The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer. J Cancer. 11(11):3246-3255.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.